Login
Register
Complete Your Profile
Change Password
Request a Password Reset
Download Documents
Download Documents
Get Help to Participate in This Tender
Change Password
For better security, update the account password.
Pharmaceuticals & Medical Devices Bureau Of India has floated a tender for Magaldrate 540mg, Simethicone 50mg and Oxetacaine 10mg Oral Suspension. The project location is New Delhi, Delhi (NCT), India. The reference number is PMBI/DRUG/RC-217/2024 and it is closing on 30 Jul 2024. Suppliers can request Register free of cost to get the complete Tender details and download the document.
Procurement Summary
State: Delhi (NCT)
Summary: Magaldrate 540mg, Simethicone 50mg and Oxetacaine 10mg Oral Suspension
Deadline: 30 Jul 2024
Posting Date: 15 Jul 2024
Other Information
Notice Type: Tender
TOT Ref.No.: 104190036
Document Ref. No.: PMBI/DRUG/RC-217/2024
Financier: Self Financed
Purchaser Ownership: Public
Document Fees: Refer Document
Tender Value: Refer Document
EMD: ₹ 1000000.00
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_details
Login to see detailsTender Details
Tenders are invited for Magaldrate 540mg, Simethicone 50mg and Oxetacaine 10mg Oral Suspension
Documents
Sign in with Google